{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T01:23:48Z","timestamp":1772587428161,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T00:00:00Z","timestamp":1518048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T00:00:00Z","timestamp":1518048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13104-018-3218-8","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T12:38:49Z","timestamp":1518093529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Seroprevalence of hepatitis B surface antigen (HBsAg) in Bo, Sierra Leone, 2012\u20132013"],"prefix":"10.1186","volume":"11","author":[{"given":"Rashid","family":"Ansumana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"3rd","given":"Donald F.","family":"Dariano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn H.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz A.","family":"Leski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph M.","family":"Lamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Lahai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umaru","family":"Bangura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred S.","family":"Bockarie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris R.","family":"Taitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chadwick","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses J.","family":"Bockarie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Stenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"key":"3218_CR1","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","volume":"388","author":"JD Stanaway","year":"2016","unstructured":"Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016;388:1081\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(16)30579-7 .","journal-title":"Lancet"},{"key":"3218_CR2","doi-asserted-by":"publisher","first-page":"469076","DOI":"10.1016\/j.jhep.2014.10.008","volume":"62","author":"M Lemoine","year":"2015","unstructured":"Lemoine M, Eholi\u00e9 S, Lacombe K. Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach. J Hepatol. 2015;62:469076. https:\/\/doi.org\/10.1016\/j.jhep.2014.10.008 .","journal-title":"J Hepatol"},{"key":"3218_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/liv.12283","volume":"34","author":"M Lemoine","year":"2014","unstructured":"Lemoine M, Thursz M, Njie R, Dusheiko G. Forgotten, not neglected: viral hepatitis in resource-limited settings, recall for action. Liver Int. 2014;34:12\u20135. https:\/\/doi.org\/10.1111\/liv.12283 .","journal-title":"Liver Int"},{"key":"3218_CR4","volume-title":"Prevention & control of viral hepatitis infection: a strategy for global action","author":"WHO","year":"2012","unstructured":"WHO. Prevention & control of viral hepatitis infection: a strategy for global action. Geneva: WHO; 2012."},{"key":"3218_CR5","volume-title":"Global health sector strategy on viral hepatitis 2016\u20132021","author":"WHO","year":"2016","unstructured":"WHO. Global health sector strategy on viral hepatitis 2016\u20132021. Geneva: WHO; 2016."},{"key":"3218_CR6","volume-title":"Transforming our world: the 2030 agenda for sustainable development","author":"UN","year":"2015","unstructured":"UN. Transforming our world: the 2030 agenda for sustainable development. New York: UN; 2015."},{"key":"3218_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2217\/fvl.13.11","volume":"8","author":"M Lemoine","year":"2013","unstructured":"Lemoine M, Nayagam S, Thursz M. Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges. Future Virol. 2013;8:371\u201380. https:\/\/doi.org\/10.2217\/fvl.13.11 .","journal-title":"Future Virol"},{"key":"3218_CR8","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","volume":"30","author":"JJ Ott","year":"2012","unstructured":"Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.116 .","journal-title":"Vaccine"},{"key":"3218_CR9","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(15)61412-X .","journal-title":"Lancet"},{"key":"3218_CR10","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Tr\u00e9po","year":"2014","unstructured":"Tr\u00e9po C, Chan HLY, Lok A. Hepatitis B virus infection. Lancet. 2014;384:2053\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(14)60220-8 .","journal-title":"Lancet"},{"key":"3218_CR11","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/j.jhep.2015.01.018","volume":"62","author":"S Locarnini","year":"2015","unstructured":"Locarnini S, Hatzakis A, Chen DS, Lok A. Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs. J Hepatol. 2015;62:S76\u201386. https:\/\/doi.org\/10.1016\/j.jhep.2015.01.018 .","journal-title":"J Hepatol"},{"key":"3218_CR12","first-page":"28","volume":"2","author":"SA Adesida","year":"2010","unstructured":"Adesida SA, Tamba GF, Sahr F, Sahr GM. Seroprevalence of human immunodeficiency and hepatitis B viruses among patients at a health facility in Freetown, Sierra Leone. Sierra Leone J Biomed Res. 2010;2:28\u201331.","journal-title":"Sierra Leone J Biomed Res"},{"key":"3218_CR13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4314\/wajm.v24i1.28156","volume":"24","author":"IM Wurie","year":"2005","unstructured":"Wurie IM, Wurie AT, Gevao SM. Sero-prevalence of hepatitis B virus among middle to high socio-economic antenatal population in Sierra Leone. West Afr J Med. 2005;24:18\u201320.","journal-title":"West Afr J Med"},{"key":"3218_CR14","first-page":"36","volume":"17","author":"M Hodges","year":"1998","unstructured":"Hodges M, Sanders E, Aitken C. Seroprevalence of hepatitis markers: HAV, HBV, HCV and HEV amongst primary school children in Freetown, Sierra Leone. West Afr J Med. 1998;17:36\u20137.","journal-title":"West Afr J Med"},{"key":"3218_CR15","first-page":"256","volume":"54","author":"H Torlesse","year":"1997","unstructured":"Torlesse H, Wurie IM, Hodges M. The use of immunochromatography test cards in the diagnosis of hepatitis B surface antigen among pregnant women in West Africa. Br J Biomed Sci. 1997;54:256\u20139.","journal-title":"Br J Biomed Sci"},{"key":"3218_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/1119-0388.198116","volume":"20","author":"EM Zoker","year":"2017","unstructured":"Zoker EM, Sundufu AJ, Jacobsen KH. Seroprevalence of hepatitis B surface antigen in urban Bo, Sierra Leone. Trop J Med Res. 2017;20:41. https:\/\/doi.org\/10.4103\/1119-0388.198116 .","journal-title":"Trop J Med Res"},{"key":"3218_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1423-0410.2009.01272.x","volume":"98","author":"H Scheiblauer","year":"2010","unstructured":"Scheiblauer H, El-Nageh M, Diaz S, Nick S, Zeichhardt H, Grunert HP, et al. Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes. Vox Sang. 2010;98:403\u201314. https:\/\/doi.org\/10.1111\/j.1423-0410.2009.01272.x .","journal-title":"Vox Sang"},{"key":"3218_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1365-3156.2011.02902.x","volume":"17","author":"BM Nagalo","year":"2012","unstructured":"Nagalo BM, Bisseye C, Sanou M, Kienou K, Nebi\u00e9 YK, Kiba A, et al. Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa. Trop Med Int Health. 2012;17:247\u201353. https:\/\/doi.org\/10.1111\/j.1365-3156.2011.02902.x .","journal-title":"Trop Med Int Health"},{"issue":"Pt 10","key":"3218_CR19","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1099\/vir.0.83102-0","volume":"88","author":"D Candotti","year":"2007","unstructured":"Candotti D, Danso K, Allain JP. Maternofetal transmission of hepatitis B virus genotype E in Ghana, West Africa. J Gen Virol. 2007;88(Pt 10):2686\u201395. https:\/\/doi.org\/10.1099\/vir.0.83102-0 .","journal-title":"J Gen Virol"},{"key":"3218_CR20","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.tracli.2009.09.004","volume":"16","author":"A Diarra","year":"2009","unstructured":"Diarra A, Kouriba B, Baby M, Murphy E, Lefrere JJ. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors. Transfus Clin Biol. 2009;16:444\u20137. https:\/\/doi.org\/10.1016\/j.tracli.2009.09.004 .","journal-title":"Transfus Clin Biol"},{"key":"3218_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.respe.2012.12.018","volume":"61","author":"Z Mayaki","year":"2013","unstructured":"Mayaki Z, Dardenne N, Kabo R, Moutschen M, Sondag D, Albert A, et al. Seroprevalence of infectious markers among blood donors in Niamey (Niger). Rev Epidemiol Sante Publique. 2013;61:233\u201340. https:\/\/doi.org\/10.1016\/j.respe.2012.12.018 .","journal-title":"Rev Epidemiol Sante Publique"},{"key":"3218_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4103\/1119-3077.151035","volume":"18","author":"BM Musa","year":"2015","unstructured":"Musa BM, Bussell S, Borodo MM, Samaila AA, Femi OL. Prevalence of hepatitis B virus infection in Nigeria, 2000\u20132013: a systematic review and meta-analysis. Niger J Clin Pract. 2015;18:163\u201372. https:\/\/doi.org\/10.4103\/1119-3077.151035 .","journal-title":"Niger J Clin Pract"},{"key":"3218_CR23","first-page":"621","volume":"68","author":"E Agbenu","year":"2008","unstructured":"Agbenu E, Banla A, Kolou M, D\u2019Almeida A, Kpotsra A, Dorkenoo A, et al. Serologic markers used for hepatitis B surveillance in Togo: status report and action proposals. Med Trop. 2008;68:621\u20134.","journal-title":"Med Trop"},{"key":"3218_CR24","volume-title":"Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection","author":"WHO","year":"2015","unstructured":"WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: WHO; 2015."},{"key":"3218_CR25","first-page":"405","volume":"84","author":"WHO","year":"2009","unstructured":"WHO. Hepatitis B vaccines. Wkly Epidemiol Rec. 2009;84:405\u201320.","journal-title":"Wkly Epidemiol Rec"},{"key":"3218_CR26","volume-title":"State of the world\u2019s children","author":"UNICEF","year":"2016","unstructured":"UNICEF. State of the world\u2019s children. New York: UNICEF; 2016."},{"key":"3218_CR27","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S2214-109X(15)00056-X","volume":"3","author":"MI Andersson","year":"2015","unstructured":"Andersson MI, Rajbhandari R, Kew MC, Vento S, Preiser W, Hoepelman AIM, et al. Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act. Lancet Glob Health. 2015;3:e358\u20139. https:\/\/doi.org\/10.1016\/S2214-109X(15)00056-X .","journal-title":"Lancet Glob Health"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-018-3218-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-018-3218-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-018-3218-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T02:37:55Z","timestamp":1660444675000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-018-3218-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3218"],"URL":"https:\/\/doi.org\/10.1186\/s13104-018-3218-8","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,8]]},"assertion":[{"value":"24 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"113"}}